Infarma LTDA (also operating as Laboratorio Infarma and Drogueria Infarma S.A.) is a Costa Rican pharmaceutical company founded in 1967 by pharmacist Dr. Edgar Acuna. It manufactures, stores, sells, and distributes pharmaceutical products, cosmetics, natural products, and dietary supplements, producing quality medicines for the whole family. As a 100% national organization headquartered in San Jose, it employs roughly 100-250 people. The company is ISO 9001 certified and holds the Essential Costa Rica country-brand license, reflecting its commitment to quality, sustainability, and social responsibility.
| Import | Export |
|---|---|
|
Trade Records
327
|
Trade Records
19
|
|
Suppliers
21
|
Buyers
5
|
|
Latest Import Date
2026-06
|
Latest Export Date
2026-08
|
According to Topease's global trade data, INFARMA LTDA. exports products to verified importers across global markets.
Its export activity is associated with HS-code categories such as:
Representative importers include:
- COMPAÑIA ASTOR SA
- DROGUERIA CAFIS DE RL CV
- SUPER FARMACIAS SIMAN S.A.-SAN PEDRO SULA AV 6 C 5 SUROESTE
These export insights help users understand the INFARMA LTDA. distribution footprint, product specialization, and shipment scale. Through Topease's deep trade data and trade intelligence capabilities—such as trade flow analysis and market benchmarking—importers and exporters can evaluate downstream demand and identify potential importer relationships.
As an importer, INFARMA LTDA. sources products from verified exporters across multiple regions.
Its import activity spans HS-code categories including:
Representative exporters include:
These import insights help users assess sourcing patterns, supplier concentration, and trade continuity. With Topease's analytical tools—such as sourcing pattern analysis and supply-chain mapping—users can evaluate supplier performance and identify diversification opportunities.
Explore INFARMA LTDA.'s import activity, including trade volumes, top suppliers, sourcing countries, and key product categories. These insights allow exporters and potential suppliers to understand its global supply chains, track procurement trends, and identify new business opportunities.
| Exporter | Importer | HS Code | Number of Trade | Amount (USD) | Quantity | Import Port |
|---|---|---|---|---|---|---|
| FOOD PACK CARRY LLC | INFARMA LTDA. | 8422 | 24 | $186,500 | 3,420 | Los Angeles |
| MOEHS PRODUCTOS QUIMICOS COPR | INFARMA LTDA. | 2932 | 24 | $186,500 | 3,420 | Los Angeles |
| HELIANTUS | INFARMA LTDA. | 1515 | 24 | $186,500 | 3,420 | Los Angeles |
| CAPSUGEL MANUFACTURING LLC | INFARMA LTDA. | 9602 | 24 | $186,500 | 3,420 | Los Angeles |
| MEDI GMBH & CO., KG BETEILIGUNGS | INFARMA LTDA. | 6115 | 24 | $186,500 | 3,420 | Los Angeles |
Gain insights into INFARMA LTDA.'s export activities, including shipment volumes, key buyers, destination countries, and product categories. Understand global demand patterns, track sales reach, and spot opportunities to connect with potential buyers.
| Importer | Exporter | HS Code | Number of Trade | Amount (USD) | Quantity | Export Port |
|---|---|---|---|---|---|---|
| COMPAÑIA ASTOR SA | INFARMA LTDA. | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| SUPER FARMACIAS SIMAN S.A.-SAN PEDRO SULA AV 6 C 5 SUROESTE | INFARMA LTDA. | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| DROGUERIA CAFIS DE RL CV | INFARMA LTDA. | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| CORPORACION IMPA-DOEL S A ONCO | INFARMA LTDA. | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| COMPAÑÍA ASTOR SA | INFARMA LTDA. | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
Chain Insights — Explore INFARMA LTDA.'s trading network to uncover connections with international buyers and suppliers. With Topease's Supply Chain Solution, you can track product flows and identify patterns that reveal new sourcing and partnership opportunities.
Access INFARMA LTDA.'s key professional contacts for B2B outreach purposes. View verified phone numbers, emails, and LinkedIn profiles to facilitate efficient business communication.
Disclaimer: Data is compiled from public and third-party sources and may not be complete or fully accurate. This information is provided for business intelligence purposes only and should not be used for legal, financial, or compliance decisions.